Abstract

Similar articles

• Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.

  Lightdale JR, Hayer C, Duer A, Lind-White C, Jenkins S, Siegel B, Elliott GR, Heyman MB.Lightdale JR, et al.Pediatrics. 2001 Nov;108(5):E90. doi: 10.1542/peds.108.5.e90.Pediatrics. 2001.PMID:11694674
• Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism.

  Carey T, Ratliff-Schaub K, Funk J, Weinle C, Myers M, Jenks J.Carey T, et al.J Autism Dev Disord. 2002 Jun;32(3):161-7. doi: 10.1023/a:1015493412224.J Autism Dev Disord. 2002.PMID:12108617Clinical Trial.
• A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.

  Corbett B, Khan K, Czapansky-Beilman D, Brady N, Dropik P, Goldman DZ, Delaney K, Sharp H, Mueller I, Shapiro E, Ziegler R.Corbett B, et al.Clin Pediatr (Phila). 2001 Jun;40(6):327-31. doi: 10.1177/000992280104000604.Clin Pediatr (Phila). 2001.PMID:11824175Clinical Trial.
• Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.

  Sturmey P.Sturmey P.Res Dev Disabil. 2005 Jan-Feb;26(1):87-97. doi: 10.1016/j.ridd.2004.09.002.Res Dev Disabil. 2005.PMID:15590241Review.
• Secretin for the treatment of autism.

  McQueen JM, Heck AM.McQueen JM, et al.Ann Pharmacother. 2002 Feb;36(2):305-11. doi: 10.1345/aph.19113.Ann Pharmacother. 2002.PMID:11847953Review.

Cited by

• Short report: Autistic gastrointestinal and eating symptoms treated with secretin: a subtype of autism.

  Pallanti S, Lassi S, La Malfa G, Campigli M, Di Rubbo R, Paolini G, Cesarali V.Pallanti S, et al.Clin Pract Epidemiol Ment Health. 2005 Nov 15;1:24. doi: 10.1186/1745-0179-1-24.Clin Pract Epidemiol Ment Health. 2005.PMID:16287506Free PMC article.
• Evaluation of regression in autism spectrum disorder based on parental reports.

  Kern JK, Geier DA, Geier MR.Kern JK, et al.N Am J Med Sci. 2014 Jan;6(1):41-7. doi: 10.4103/1947-2714.125867.N Am J Med Sci. 2014.PMID:24678477Free PMC article.
• Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).

  Iffland M, Livingstone N, Jorgensen M, Hazell P, Gillies D.Iffland M, et al.Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2.Cochrane Database Syst Rev. 2023.PMID:37811711Free PMC article.Review.
• Global hormone profiling of murine placenta reveals Secretin expression.

  Knox K, Leuenberger D, Penn AA, Baker JC.Knox K, et al.Placenta. 2011 Nov;32(11):811-6. doi: 10.1016/j.placenta.2011.08.013. Epub 2011 Sep 25.Placenta. 2011.PMID:21944867Free PMC article.
• Secretin receptor-deficient mice exhibit impaired synaptic plasticity and social behavior.

  Nishijima I, Yamagata T, Spencer CM, Weeber EJ, Alekseyenko O, Sweatt JD, Momoi MY, Ito M, Armstrong DL, Nelson DL, Paylor R, Bradley A.Nishijima I, et al.Hum Mol Genet. 2006 Nov 1;15(21):3241-50. doi: 10.1093/hmg/ddl402. Epub 2006 Sep 28.Hum Mol Genet. 2006.PMID:17008357Free PMC article.

References

Publication types

• Clinical Trial
• Randomized Controlled Trial

MeSH terms

• Autistic Disorder / complications
• Autistic Disorder / diagnosis
• Autistic Disorder / drug therapy*
• Child
• Child Development Disorders, Pervasive / complications
• Child Development Disorders, Pervasive / diagnosis
• Child Development Disorders, Pervasive / drug therapy*
• Child, Preschool
• Chronic Disease
• Comorbidity
• Constipation / complications
• Constipation / drug therapy
• Cross-Over Studies
• Diarrhea / complications
• Diarrhea / drug therapy
• Double-Blind Method
• Female
• Humans
• Male
• Personality Assessment
• Secretin / adverse effects
• Secretin / therapeutic use*
• Treatment Outcome

Substances

• Secretin

Related information

• Cited in Books
• MedGen
• PubChem Compound (MeSH Keyword)

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.